The largest database of trusted experimental protocols

2019 ncov n positive control

Manufactured by Integrated DNA Technologies
Sourced in United States

The 2019-nCoV_N_Positive Control is a laboratory reagent used for quality control and validation purposes. It contains a synthetic DNA sequence that corresponds to a region of the nucleocapsid (N) gene of the SARS-CoV-2 virus. This control material can be used to monitor the performance of molecular diagnostic tests targeting the SARS-CoV-2 N gene.

Automatically generated - may contain errors

22 protocols using 2019 ncov n positive control

1

SARS-CoV-2 Quantification in Remdesivir-Treated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SARS-CoV-2 strain JPN/TY/WK-52120 was distributed by the National Institute of Infectious Diseases in Japan. After pretreatment with remdesivir (1 μM) for 1 h, the cells were infected with SARS-CoV-2 at a multiplicity of infection (MOI) of 1 for 24 h. After infection, intracellular RNA was extracted using the CellAmp Direct RNA Prep Kit (Takara Bio, Shiga, Japan), according to the manufacturer's instructions. Quantitative real-time PCR was performed using TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher Scientific), 2019-nCoV RUO Kit (Integrated DNA Technologies, Coralville, Iowa, USA), and 2019-nCoV_N positive control (Integrated DNA Technologies) with a QuantStudio 7 Flex Real-Time PCR System (Thermo Fisher Scientific).
+ Open protocol
+ Expand
2

Establishing SARS-CoV-2 LamPORE Detection Limits

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spiked samples were prepared and analyzed at PHE Porton Down to establish the limits of detection of LamPORE. Aliquots of pooled volunteer saliva were used for spiking experiments, which were confirmed SARS-CoV-2 negative by RT-PCR. They were spiked with cultured SARS-CoV-2 (Victoria/01/202026 passaged twice in Vero/hSLAM cells) at 1,000 SARS-CoV-2 genome copies/ml of sample and serially diluted with the remaining material to create a dilution series of positive samples.
RNA was extracted from 360 μl of the spiked sample using the QiaAMP viral RNA minikit (Qiagen), with RNA eluted in 36 μl. Reference RT-PCR was conducted with the CDC NS1 assay with 5-μl RNA input (10 ). Quantification was determined by comparison to a standard curve of a plasmid 2019-nCoV_N positive control (Integrated DNA Technologies). Further details are in the supplemental material.
+ Open protocol
+ Expand
3

Quantifying SARS-CoV-2 in Wastewater by RT-qPCR

Check if the same lab product or an alternative is used in the 5 most similar protocols
RT-qPCR was performed directly to quantify the SARS-CoV-2 in the wastewater samples with the premixed primer and probes set 2019-nCoV RUO Kit (Integrated DNA Technologies, Inc., Coralville, IA, USA). A combination of the N1 and N2 primers and probes set was chosen because a study showed that this duplex qPCR assay increased the sensitivity of SARS-CoV-2 detection in wastewater [20 (link)]. The sequences of the primers and probes were found in the study of Qiu et al. [21 (link)]. Each reaction contains the wastewater sample as the template, N1 and N2 primers/probes, and the PowerSYBR Green PCR Master Mix (Applied Biosystems, Warrington, UK). The amplification process was performed with the AB StepOne RT-PCR System (Applied Biosystems, Foster City, CA, USA). Samples were considered positive if amplification was achieved within a cycle threshold of less than 40 cycles (Ct < 40) for at least two out of the triplicates. Dilutions of the 2019nCoV_N Positive Control (Integrated DNA Technologies, Inc., Coralville, IA, USA) were prepared in triplicates to generate a standard curve that was used to calculate the gene copy number (GCN) of SARS-CoV-2.
+ Open protocol
+ Expand
4

Evaluating SARS-CoV-2 Inhibitors in iPSC-BMELCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The SARS-CoV-2 original strain JPN/TY/WK-521 [27 (link)] was distributed by the National Institute of Infectious Diseases in Japan. After pretreatment with the indicated reagents (ACE2 Ab, Meplazumab, Bemcentinib, EG00229, CHIR99021) for 1 h, SARS-CoV-2 was allowed to infect human iPSC-BMELCs at a multiplicity of infection (MOI) of 1 for 24 h. After infection, the cells were washed once with a washing buffer and intracellular RNA was extracted using the CellAmp Direct RNA Prep Kit (Takara Bio, Shiga, Japan), according to the manufacturer’s instructions. Quantitative real-time PCR was performed using TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher Scientific), 2019-nCoV RUO Kit (Integrated DNA Technologies, Coralville, Iowa, USA), and 2019-nCoV_N positive control (Integrated DNA Technologies) with a QuantStudio 7 Flex Real-Time PCR System (Thermo Fisher Scientific).
+ Open protocol
+ Expand
5

SARS-CoV-2 RNA Detection in Organotypic Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Viral RNA was isolated from organotypic cultures using the QIAamp viral RNA extraction kit (Qiagen, Verlo, The Netherlands) following manufacturer’s instructions and quantified using a Nanodrop™ (ThermoFisher Scientific). Total RNA from organotypic slices were isolated using the RNeasy mini kit (Qiagen) and quantified using the Nanodrop. cDNA was generated using the high-capacity cDNA reverse transcriptase (ThermoFisher Scientific). Real-time PCR was carried out using the Taqpath reagent (ThermoFisher Scientific) and the primers/probes recommended by the US CDC SARS-CoV-2 RUO qPCR Primer & Probe Kit for N1 (catalog #10006713, Integrated DNA Technologies) with 2019-nCoV_N_Positive Control (catalog #10006625, Integrated DNA Technologies).
+ Open protocol
+ Expand
6

SARS-CoV-2 RT-LAMP Viral Load Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
The RNA control was serially diluted in nuclease-free water and analyzed by RT-qPCR to obtain the corresponding amplification cycle threshold (Ct). The viral genomic copies were calculated by plotting Ct values onto the standard curve constructed based on the 2019-nCoV_N_Positive Control (Integrated DNA Technologies, Iowa, USA). Samples with a concentration ranging from 2.1 × 105 to 8.5 × 102 were analyzed by RT-LAMP in octuplicates. We performed a Probit analysis to determine the limit of detection (LOD) using MedCalc software (Version 19.6.4, MedCalc software, Ostend, Belgium), giving a value of C95 (95% detection probability across all replicates). The RT-LAMP products of amplification were determined by visual observation and confirmed by gel electrophoresis (2% agarose and 0.5% Tris–EDTA–borate (TEB) buffer).
+ Open protocol
+ Expand
7

SARS-CoV-2 Viral Load Quantification from Stool

Check if the same lab product or an alternative is used in the 5 most similar protocols
SARS-CoV-2 virus loads were measured via RT-qPCR as described in Zuo et al.10 (link) RNA was extracted from 0.1 g homogenised stools using the QIAamp Viral RNA Mini Kit (QIAGEN, Hilden Germany) following manufacturer’s instructions. SARS-CoV-2 primer and probe sequences were as provided by the US Centers for Disease Control and Prevention (2019-nCoV_N1-F: 5'-GACCCCAAAATCAGC GAAAT-3', 2019-nCoV_N1-R: 5'-TCTGGTTACTGCCAGTTGAATCTG-3' and 2019-nCoV_N1-P: 5'-FAM-ACCCCGCATTACGTTTGGTGGACC-BHQ1-3'). Each one-step RT-qPCR reaction contained 10 µL of extracted RNA, 4 µL TaqMan Fast Virus 1-Step Master Mix (Thermo Fisher Scientific, Massachusetts, USA) in a final reaction volume of 20 µL. Primer and probe concentrations were 0.5 µM and 0.125 µM, respectively. Cycling conditions were 25°C for 2 min, 50°C for 15 min, 95°C for 2 min, followed by 45 cycles of 95°C for 15 s and 55°C for 30 s. Thermocycling was performed on a StepOnePlus Real-Time PCR System (Thermo Fisher Scientific). Cycle threshold (Ct) values were converted into viral RNA copies based on a standard curve prepared from 10-fold serial dilutions of known copies of plasmids containing the full N gene (2019-nCoV_N_Positive Control, Integrated DNA Technologies, USA). Samples were considered negative if Ct values exceeded 39.9 cycles. The detection limit was 347 copies/mL.
+ Open protocol
+ Expand
8

Digital Droplet PCR for SARS-CoV-2 Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
QX200 droplet generator (Bio-Rad, #1864002) was used to make emulsions following the manufacture’s instruction. Briefly, 20 μL reaction mix was prepared using ddPCR Supermix for Probe (no dUTP) (Bio-Rad, #1863024), N2 outer primers (F: AAC ACA AGC TTT CGG CAG AC, R:CCC GAA GGT GTG ACT TCC AT; final concentration of 500 nM) and template (2019-nCoV_N_Positive Control, Integrated DNA Technologies, #10006625). The ddPCR reaction mix was added to the droplet generator and converted to droplets with the use of Droplet Generation Oil for Probes (Bio-Rad, #1863005) and DG8 Cartridges and Gaskets (Bio-Rad, # 1864007).
+ Open protocol
+ Expand
9

SARS-CoV-2 Nucleocapsid Positive Control

Check if the same lab product or an alternative is used in the 5 most similar protocols
Positive control plasmid containing the full length nucleocapsid coding sequence (N) was purchased at Integrated DNA Technologies (2019-nCoV_N_Positive Control; cat. no. 10006625). Plasmid was supplied at a final concentration of 200 000 copies/μL in IDTE pH = 8 buffer, and has been used to evaluate both the detection efficiency and sensitivity of the BiomarkHD System Analysis.
+ Open protocol
+ Expand
10

E. coli and SARS-CoV-2 Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Escherichia coli O157:H7 (part number 0801622; ZeptoMetrix Corporation, Buffalo, NY, USA) was used as a proof-of-concept target. The stock bacterial solution was diluted to different concentrations of 106, 103, 1, 0.1, and 0 CFU/μL in nuclease free water. For SARS-CoV-2 detection, 2019-nCoV_N_Positive Control (catalog number 10006625; Integrated DNA Technologies, Coralville, IA, USA) stock solution was diluted to different concentrations of 105, 103, 101, and 0 copies/μL in nuclease free water.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!